Listed by the USPTO as SCHACHERMEYER, SAMANTHA LYNN
Tech Center 1600 • Art Units: 1693
This examiner grants 36% of resolved cases
SCHACHERMEYER, SAMANTHA LYNN has 42 resolved cases and an allowance rate of 35.7%. The median time to allowance is 1232 days. Interviews correspond to a 70.8% lift in the allowance rate, the largest interview association reported in this profile. Applicants may therefore give substantial attention to interview preparation, while recognizing that the limited resolved-case volume makes matter-specific analysis important.
The listed companies are Boston Scientific Corporation, AbbVie Inc., and The Ohio State University. The listed firms are UVA-Jenkins, Taylor & Hunt, Arnold & Porter Kaye Scholer LLP - Roquette Freres, and BIRCH STEWART KOLASCH & BIRCH, LLP. These names identify the applicant and counsel experience available for comparison within the docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18761777 | BORONATED HYDROGELS AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | Boston Scientific Scimed, Inc. |
| 17995798 | METHODS OF TREATING DIABETIC KIDNEY DISEASE | Final Rejection | AbbVie Inc. |
| 18276397 | SMALL MOLECULE INHIBITORS OF CD38 AS IMMUNOSUPPRESSANTS | Final Rejection | OHIO STATE INNOVATION FOUNDATION |
| 18002301 | COMPOSITIONS COMPRISING MYO-INOSITOL AND THEIR USE IN THE PREVENTION OF POST PARTUM HAEMORRHAGE (PPH) | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18279517 | THE USE OF EMPAGLIFLOZIN FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE | Final Rejection | The Governors of the University of Alberta |
| 17775213 | CERAMIDE ANALOG SACLAC MODULATES SPHINGOLIPID LEVELS AND MCL-1 SPLICING TO INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA | Final Rejection | University of Virginia Patent Foundation |
| 18557304 | Galactooligosaccharides for improving immune response | Final Rejection | N.V. Nutricia |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy35.7% of resolved applications examined by Samantha Lynn Schachermeyer were allowed (42 resolved cases), compared with 59.4% across Art Unit 1693 over the last five years.
This examiner's interview lift is +70.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Samantha Lynn Schachermeyer took 1,232 days on average from filing to allowance.
Samantha Lynn Schachermeyer examines applications in Art Unit 1693 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
